These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23551351)

  • 1. Case report: Beneficial effect of 11β-hydroxylase inhibitor in the management of an elderly patient with an androgen-producing inoperable adrenal tumor.
    Ozawa W; Sato K; Miyakoshi T; Nishio S; Yamazaki M; Suzuki S; Komatsu M
    Geriatr Gerontol Int; 2013 Apr; 13(2):509-11. PubMed ID: 23551351
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women.
    Koutkia P; Berry J; Eaton K; Breu J; Grinspoon S
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E808-13. PubMed ID: 16303845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone.
    Monaghan PJ; Owen LJ; Trainer PJ; Brabant G; Keevil BG; Darby D
    Ann Clin Biochem; 2011 Sep; 48(Pt 5):441-6. PubMed ID: 21813575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone.
    Halsall DJ; Gurnell M
    Ann Clin Biochem; 2012 Mar; 49(Pt 2):204; author reply 204-5. PubMed ID: 22337707
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia.
    Yoshida M; Umeda H; Iwama S; Nakayama S; Miyata M; Ogawa K; Maeda H; Oiso Y
    Endocrine; 2012 Feb; 41(1):160-1. PubMed ID: 22038492
    [No Abstract]   [Full Text] [Related]  

  • 6. Metyrapone treatment in Cushing's syndrome: a real-life study.
    Ceccato F; Zilio M; Barbot M; Albiger N; Antonelli G; Plebani M; Watutantrige-Fernando S; Sabbadin C; Boscaro M; Scaroni C
    Endocrine; 2018 Dec; 62(3):701-711. PubMed ID: 30014438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical treatment for Cushing's syndrome].
    Nishikawa T; Saito J; Omura M
    Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cushing's syndrome].
    Shimizu N; Kato T
    Naika; 1971 Jun; 27(6):1202-6. PubMed ID: 4326410
    [No Abstract]   [Full Text] [Related]  

  • 9. Metyrapone for Cushing's syndrome.
    Inagaki M; Akizuki N; Kugaya A; Fujii H; Akechi T; Uchitomi Y
    Am J Psychiatry; 2002 Jul; 159(7):1246. PubMed ID: 12091216
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative management of Cushing's syndrome with metyrapone for severe psychiatric disturbances.
    Obinata D; Yamaguchi K; Hirano D; Yoshida T; Soma M; Takahashi S
    Int J Urol; 2008 Apr; 15(4):361-2. PubMed ID: 18380829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic and pharmacokinetic characterization of the aldosterone synthase inhibitor FAD286 in two rodent models of hyperaldosteronism: comparison with the 11beta-hydroxylase inhibitor metyrapone.
    Rigel DF; Fu F; Beil M; Hu CW; Liang G; Jeng AY
    J Pharmacol Exp Ther; 2010 Jul; 334(1):232-43. PubMed ID: 20354176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
    Halioui-Louhaichi S; Azzabi O; Nefzi L; Ben Hariz M; Ben Mrad N; Ben Ammar B; Maherzi A
    Arch Pediatr; 2005 Jul; 12(7):1120-3. PubMed ID: 15964528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.
    Creemers SG; Feelders RA; de Jong FH; Franssen GJH; de Rijke YB; van Koetsveld PM; Hofland LJ
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3437-3449. PubMed ID: 31127821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxyphil metaplasia of adrenal cortex secondary to metyrapone therapy.
    Suvarna SK; Stephenson TJ
    Histopathology; 2001 Nov; 39(5):546-7. PubMed ID: 11737320
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitors of 11β-Hydroxylase (CYP11B1) for Treating Diseases Related to Excess Cortisol.
    Zhu W; Chen Z; Li Q; Tan G; Hu G
    Curr Med Chem; 2016; 23(6):623-33. PubMed ID: 26795197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndrome.
    Yin L; Lucas S; Maurer F; Kazmaier U; Hu Q; Hartmann RW
    J Med Chem; 2012 Jul; 55(14):6629-33. PubMed ID: 22788843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study.
    Kablinger AS; Lindner MA; Casso S; Hefti F; DeMuth G; Fox BS; McNair LA; McCarthy BG; Goeders NE
    J Psychopharmacol; 2012 Jul; 26(7):973-81. PubMed ID: 22236504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
    Kellner M; Otte C; Yassouridis A; Schick M; Jahn H; Wiedemann K
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):337-9. PubMed ID: 15163445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
    Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.